These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10466430)

  • 1. FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors.
    Smardová J
    Neoplasma; 1999; 46(2):80-8. PubMed ID: 10466430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional screening of p53 status in tumor cells using Saccharomyces cerevisiae].
    Jia LQ; Ishioka C; Osada M; Gamo M; Shimodaira H; Suzuki T; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):466-70. PubMed ID: 9063485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
    Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening patients for heterozygous p53 mutations using a functional assay in yeast.
    Ishioka C; Frebourg T; Yan YX; Vidal M; Friend SH; Schmidt S; Iggo R
    Nat Genet; 1993 Oct; 5(2):124-9. PubMed ID: 8252037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
    Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder.
    Dekairelle AF; Tombal B; Cosyns JP; Gala JL
    Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.
    Deissler H; Kafka A; Schuster E; Sauer G; Kreienberg R; Zeillinger R
    Oncol Rep; 2004 Jun; 11(6):1281-6. PubMed ID: 15138567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of p53 tumor suppressor in yeast.
    Smardová J; Smarda J; Koptíková J
    Differentiation; 2005 Jul; 73(6):261-77. PubMed ID: 16138827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of yeast functional assay to detect p53 gene mutation in minute endoscopic samples of colonic mucosal neoplasia].
    Nakamura Y
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):505-17. PubMed ID: 9846280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of transcript mutations due to transcriptional slippage in rat p53 tumor suppressor gene with the use of yeast functional assay].
    Ba Y
    Hokkaido Igaku Zasshi; 1999 May; 74(3):173-88. PubMed ID: 10422562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a transcriptionally inactive p53 mutant by functional analysis of separated alleles in yeasts (FASAY) in a child osteosarcoma tumor: a case report.
    Dekairelle AF; Brichard B; Delhez H; Gala JL
    Pediatr Hematol Oncol; 2004 Jun; 21(4):321-8. PubMed ID: 15205094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.
    Watanabe J; Nishiyama H; Okubo K; Takahashi T; Toda Y; Habuchi T; Kakehi Y; Tada M; Ogawa O
    Urology; 2004 May; 63(5):989-93. PubMed ID: 15135005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
    Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
    Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.
    Pfister C; Flaman JM; Martin C; Grise P; Frebourg T
    J Urol; 1999 Jun; 161(6):1973-5. PubMed ID: 10332483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.
    Duddy PM; Hanby AM; Barnes DM; Camplejohn RS
    J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast.
    Pavlova S; Mayer J; Koukalova H; Smardova J
    Int J Oncol; 2003 Jul; 23(1):121-31. PubMed ID: 12792784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.
    Fouquet C; Antoine M; Tisserand P; Favis R; Wislez M; Commo F; Rabbe N; Carette MF; Milleron B; Barany F; Cadranel J; Zalcman G; Soussi T
    Clin Cancer Res; 2004 May; 10(10):3479-89. PubMed ID: 15161705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly sensitive detection method for somatic mutations in p53 gene.
    Sato T; Sato A; Ishihara H; Konishi K
    Rinsho Byori; 2003 Feb; 51(2):98-106. PubMed ID: 12690626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of mouse p53 yeast functional assay and evaluation of its detectability of p53 gene mutation].
    Tsunematsu I
    Hokkaido Igaku Zasshi; 1999 Jul; 74(4):301-14. PubMed ID: 10480037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.